Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.
about
Topotecan inhibits human immunodeficiency virus type 1 infection through a topoisomerase-independent mechanism in a cell line with altered topoisomerase IRole for human immunodeficiency virus type 1 Tat protein in suppression of viral reverse transcriptase activity during late stages of viral replication.Functional genomics in HIV-1 virus replication: protein-protein interactions as a basis for recruiting the host cell machinery for viral propagation.A Leu to Ile but not Leu to Val change at HIV-1 reverse transcriptase codon 74 in the background of K65R mutation leads to an increased processivity of K65R+L74I enzyme and a replication competent virus.Activity of the human immunodeficiency virus type 1 cell cycle-dependent internal ribosomal entry site is modulated by IRES trans-acting factorsHuman topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.Reverse Transcriptase and Cellular Factors: Regulators of HIV-1 Reverse Transcription.Discontinuous plus-strand DNA synthesis in human immunodeficiency virus type 1-infected cells and in a partially reconstituted cell-free systemDNA topoisomerase 1 facilitates the transcription and replication of the Ebola virus genome.Coregulation of HIV-1 dependency factors in individuals heterozygous to the CCR5-delta32 deletion.Comparative analysis of in vitro processivity of HIV-1 reverse transcriptases containing mutations 65R, 74V, 184V and 65R+74V.HIV-1-associated PKA acts as a cofactor for genome reverse transcription.Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsidTat is required for efficient HIV-1 reverse transcription.Detection and sequence analysis of hepatitis B virus integration in peripheral blood mononuclear cells.Efficient in vitro inhibition of HIV-1 gag reverse transcription by peptide nucleic acid (PNA) at minimal ratios of PNA/RNA.Nucleolin and the packaging signal, psi, promote the budding of human immunodeficiency virus type-1 (HIV-1).
P2860
Q28378884-64833A48-036C-4E18-9B3D-E7E2738D66ADQ33865436-966256F7-6EF0-4F87-97BD-94F71C1D89F0Q34352239-F2F25D1B-F361-4237-AA32-B73E4F0F6DBBQ34573897-10D315FE-8008-490F-84C8-20C8B4124388Q35153487-5FF61FB1-3B2D-4BDA-8EAD-F9B756ECEFDFQ35168345-E448815B-54B7-4F48-B26E-9A3C987194DDQ35260021-A203C644-D025-4F7B-9DE5-308DF247C42CQ36548782-36B6E624-266D-44AC-9F28-84E6724F0606Q37123264-486FBED4-FB9E-4062-ACC3-19160ECDAE05Q37326697-290BC948-7438-46A5-8995-783E79A5E11CQ37404676-479EBFCC-9E3C-4487-BAA2-74D6AFA40378Q37430491-E7A463F5-D96A-49CF-90B8-D0B6973B3131Q37730078-70C2F289-1181-4A32-9B6D-021741B553A4Q38347693-CDAFD331-2CC4-4F50-976B-C6F1D95ADFCBQ39549331-B40EA750-D84D-4F7D-9842-A9F9B335A0EFQ39720212-A6F0149B-8684-4B09-82E4-287B85B40199Q45673844-C442B01C-71DD-4351-BDCA-54461B474ADD
P2860
Human immunodeficiency virus type 1 reverse transcriptase: enhancement of activity by interaction with cellular topoisomerase I.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@ast
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@en
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@nl
type
label
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@ast
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@en
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@nl
prefLabel
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@ast
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@en
Human immunodeficiency virus t ...... with cellular topoisomerase I.
@nl
P2093
P2860
P356
P1476
Human immunodeficiency virus t ...... with cellular topoisomerase I
@en
P2093
H Takahashi
K Nagashima
P2860
P304
P356
10.1073/PNAS.92.12.5694
P407
P577
1995-06-01T00:00:00Z